We welcome treatments that may help people manage or slow their symptoms of dementia mate wareware and are often asked about the benefits of different medication.
There has been a lot of exciting media coverage lately, specifically around Aducanumab, Lecanemab and Donanemab.
Our team of experts, the Clinical and Scientific Advisory Group, can see some benefits but there are still doubts around the clinical significance of the trials. These new agents represent a scientific step forward even though they are not a significant clinical step forward.
Get in touch with your GP, nurse practitioner or Māori health provider for more information and advice about medication.